Related Experiment Videos
IgA antibodies recognizing LABD97 are predominantly IgA1 subclass
C A Egan1, M R Martineau, T B Taylor
1Department of Dermatology, University of Utah School of Medicine, Salt Lake City 84132, USA. C.A.Egan@m.cc.utah.edu
Acta Dermato-Venereologica
|September 24, 1999
Summary
Linear IgA bullous dermatosis (LABD) involves IgA1 antibodies against LABD97. While IgA1 is predominant, some LABD patients also show IgA2 subclass involvement, indicating a complex immune response in this rare skin condition.
Area of Science:
- Immunodermatology
- Autoimmune Blistering Diseases
- Molecular Immunology
Background:
- Linear IgA bullous dermatosis (LABD) is a rare acquired subepidermal blistering skin disease.
- A key antigen in LABD is the 97-kDa basement membrane zone protein, LABD97.
- Prior research suggested IgA response in LABD is primarily IgA1 subclass.
Purpose of the Study:
- To investigate IgA antibody subclasses against LABD97 in patients with LABD.
- To determine the prevalence of IgA1 and IgA2 subclasses in anti-LABD97 antibodies.
Main Methods:
- Sera from 6 LABD patients with circulating IgA antibodies to LABD97 were analyzed.
- Techniques included direct and indirect immunofluorescence and Western immunoblot.
- Antibody subclass reactivity (IgA1 and IgA2) against LABD97 was assessed.
Main Results:
- All 6 patients demonstrated IgA1 anti-LABD97 antibodies via all tested methods.
- IgA2 anti-LABD97 antibodies were detected in 2 patients by direct immunofluorescence.
- Further IgA2 reactivity was observed in 3 patients via indirect immunofluorescence and Western immunoblot.
Conclusions:
- The primary IgA antibody subclass targeting LABD97 in LABD is IgA1.
- However, the IgA2 subclass may play a role in the autoimmune response in a subset of LABD patients.